ArticleJournal of clinical medicine2024

Real-World Effectiveness and Safety of Selective JAK Inhibitors in Ulcerative Colitis and Crohn's Disease: A Retrospective, Multicentre Study.

Bernadett Farkas et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.